APA (7th ed.) Citation

JN, B., SP, H., SW, S., CK, B., KN, K., MA, L., . . . JB, K. (2026). Optimization of methylated DNA markers to rule out endometrial cancer in patients with abnormal uterine bleeding. Gynecologic oncology, 208, 91. https://doi.org/10.1016/j.ygyno.2026.03.013

Chicago Style (17th ed.) Citation

JN, Bakkum-Gamez, et al. "Optimization of Methylated DNA Markers to Rule Out Endometrial Cancer in Patients with Abnormal Uterine Bleeding." Gynecologic Oncology 208 (2026): 91. https://doi.org/10.1016/j.ygyno.2026.03.013.

MLA (9th ed.) Citation

JN, Bakkum-Gamez, et al. "Optimization of Methylated DNA Markers to Rule Out Endometrial Cancer in Patients with Abnormal Uterine Bleeding." Gynecologic Oncology, vol. 208, 2026, p. 91, https://doi.org/10.1016/j.ygyno.2026.03.013.